Brian Morse

1.5k total citations
31 papers, 1.1k citations indexed

About

Brian Morse is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Brian Morse has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Epidemiology and 13 papers in Neurology. Recurrent topics in Brian Morse's work include Neuroendocrine Tumor Research Advances (18 papers), Lung Cancer Research Studies (14 papers) and Neuroblastoma Research and Treatments (13 papers). Brian Morse is often cited by papers focused on Neuroendocrine Tumor Research Advances (18 papers), Lung Cancer Research Studies (14 papers) and Neuroblastoma Research and Treatments (13 papers). Brian Morse collaborates with scholars based in United States, Japan and Canada. Brian Morse's co-authors include Jonathan Strosberg, Alvin C. Silva, Robert G. Paden, Amy K. Hara, Norio Hongo, William Pavlicek, Taymeyah Al‐Toubah, Mauro Cives, Emily K. Bergsland and Calvin Law and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Medicine.

In The Last Decade

Brian Morse

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Morse United States 14 634 622 451 294 256 31 1.1k
Murat Fani Bozkurt Türkiye 13 443 0.7× 491 0.8× 311 0.7× 249 0.8× 46 0.2× 63 1.0k
Stephen E. McRae United States 9 278 0.4× 281 0.5× 225 0.5× 83 0.3× 30 0.1× 16 608
F. Vorbeck Austria 15 222 0.4× 211 0.3× 127 0.3× 143 0.5× 27 0.1× 29 588
Laméris Js Netherlands 12 440 0.7× 424 0.7× 242 0.5× 207 0.7× 23 0.1× 30 1.1k
Rob van Os Netherlands 10 102 0.2× 196 0.3× 126 0.3× 106 0.4× 98 0.4× 16 760
Koji Takumi Japan 17 295 0.5× 243 0.4× 52 0.1× 526 1.8× 81 0.3× 70 934
Alexander König Germany 15 285 0.4× 143 0.2× 133 0.3× 77 0.3× 78 0.3× 36 691
Shudong Hu China 17 188 0.3× 58 0.1× 54 0.1× 367 1.2× 126 0.5× 74 665
Byung Hee Lee South Korea 15 110 0.2× 144 0.2× 192 0.4× 190 0.6× 26 0.1× 58 857
S A Sohaib United Kingdom 12 139 0.2× 119 0.2× 87 0.2× 189 0.6× 47 0.2× 20 642

Countries citing papers authored by Brian Morse

Since Specialization
Citations

This map shows the geographic impact of Brian Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Morse more than expected).

Fields of papers citing papers by Brian Morse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Morse. The network helps show where Brian Morse may publish in the future.

Co-authorship network of co-authors of Brian Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Morse. A scholar is included among the top collaborators of Brian Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Morse. Brian Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morse, Brian, et al.. (2025). Preoperative prediction of high‐risk lymph nodes in penile cancer: Graafland criteria vs radiomics. British Journal of Urology. 136(1). 45–46.
2.
Jeong, Daniel, Brian Morse, Dung‐Tsa Chen, et al.. (2024). Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to Pathology. Cancers. 16(1). 206–206. 2 indexed citations
3.
Al‐Toubah, Taymeyah, et al.. (2024). Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors. ESMO Open. 9(4). 102386–102386. 6 indexed citations
4.
Pellè, Eleonora, Taymeyah Al‐Toubah, Brian Morse, & Jonathan Strosberg. (2022). Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine Tumor.. PubMed. 20(12). 1285–1287. 7 indexed citations
5.
Al‐Toubah, Taymeyah, Brian Morse, & Jonathan Strosberg. (2022). Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors. Current Oncology. 29(2). 510–515. 9 indexed citations
6.
Pellè, Eleonora, Taymeyah Al‐Toubah, Brian Morse, Ghassan El‐Haddad, & Jonathan Strosberg. (2021). Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy. Journal of Neuroendocrinology. 33(2). e12936–e12936. 4 indexed citations
7.
Al‐Toubah, Taymeyah, et al.. (2021). Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms. ESMO Open. 7(1). 100364–100364. 32 indexed citations
8.
Morse, Brian & Jason Klapman. (2020). Imaging of Pancreatic Tumors. PubMed. 26. 21–33.
9.
Morse, Brian, Danielle K. DePeralta, Anupam Rishi, et al.. (2020). Liver-directed treatments of liver-dominant metastatic leiomyosarcoma. Diagnostic and Interventional Radiology. 26(5). 449–455. 7 indexed citations
10.
Morse, Brian, et al.. (2020). Anatomic and Functional Imaging of Neuroendocrine Tumors. Current Treatment Options in Oncology. 21(9). 75–75. 8 indexed citations
11.
Morse, Brian, et al.. (2019). Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease. SHILAP Revista de lepidopterología. 2019. 1–4. 4 indexed citations
12.
Morse, Brian, et al.. (2018). Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment. Abdominal Radiology. 44(2). 766–774. 21 indexed citations
13.
Howe, James R., Kenneth Cardona, Douglas L. Fraker, et al.. (2017). The Surgical Management of Small Bowel Neuroendocrine Tumors. Pancreas. 46(6). 715–731. 233 indexed citations
14.
Strosberg, Jonathan, Mauro Cives, Justin H. Hwang, et al.. (2016). A phase II study of axitinib in advanced neuroendocrine tumors. Endocrine Related Cancer. 23(5). 411–418. 47 indexed citations
15.
Cives, Mauro, Masoumeh Ghayouri, Brian Morse, et al.. (2016). Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors. Endocrine Related Cancer. 23(9). 759–767. 119 indexed citations
16.
Kim, Richard D., Nishi Kothari, Mokenge P. Malafa, et al.. (2015). PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer. Clinical Nuclear Medicine. 40(11). e501–e505. 27 indexed citations
17.
Morse, Brian, Barbara A. Centeno, & Shivakumar Vignesh. (2014). Autoimmune Pancreatitis: Updated Concepts of a Challenging Diagnosis. The American Journal of Medicine. 127(10). 1010.e1–1010.e9. 6 indexed citations
18.
Morse, Brian, et al.. (2012). Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series. Neuroendocrinology. 97(4). 318–321. 20 indexed citations
19.
Silva, Alvin C., Brian Morse, Amy K. Hara, et al.. (2011). Dual-Energy (Spectral) CT: Applications in Abdominal Imaging. Radiographics. 31(4). 1031–1046. 280 indexed citations
20.
Nuss, Geoffrey R., Allen F. Morey, Jeffrey H. Pruitt, et al.. (2009). Radiographic Predictors of Need for Angiographic Embolization After Traumatic Renal Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 67(3). 578–582. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026